Office management of early induced abortion

Clinical Obstetrics and Gynecology

Volumn 42, Issue 2, 1999, Pages 290-305

  Paul, Maureen ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Planned Parenthood League of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; CARBOPROST; CHORIONIC GONADOTROPIN BETA SUBUNIT; COCODAMOL; METHOTREXATE; METHYLERGOMETRINE; MIFEPRISTONE; MISOPROSTOL; NARCOTIC ANALGESIC AGENT; VASOPRESSIN;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CURETTAGE; DRUG EFFICACY; DRUG SAFETY; DYSTOCIA; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; PELVIC INFLAMMATORY DISEASE; POSTOPERATIVE CARE; PREGNANCY TEST; SIDE EFFECT; TRANSVAGINAL ECHOGRAPHY; UTERUS BLEEDING; UTERUS PERFORATION; VACUUM ASPIRATION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; AMBULATORY CARE; FEMALE; HUMANS; METHOTREXATE; MISOPROSTOL; OFFICE VISITS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 0033371811     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199906000-00012     Document Type: Article

References (20)

1. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998; 30:24-29, 46.
2. Edwards J, Carson SA. New technologies permit safe abortion at less than 6 weeks' gestation and provide timely detection of ectopic gestation. Am J Obstet Gynecol. 1997;176:1101-1106.
3. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect. 1995;27:142-148, 185.
4. Sawaya GF, Grady D, Kerlikowski K, Grimes DA. Antibiotics at the time of induced abortion: The case for universal prophylaxis based on a meta-analysis. Obstet Gynecol. 1996;87:884-890.
5. Grimes DA, Schulz KF, Cates W Jr. Prevention of uterine perforation during curettage abortion. JAMA 1984;251:2108-2111.
6. Singh K, Fong YF, Prasad RNV, Dong F. Randomized trial to determine optimal dose of vaginal misoprostol for preabortion cervical priming. Obstet Gynecol. 1998;92: 795-798.
7. Wiebe ER, Rawling M. Pain control in abortion. Int J Gynecol Obstet. 1995;50: 41-46.
8. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92.
9. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med. 1995; 332:983-987.
10. Grimes DA. Medical abortion in early pregnancy: A review of the evidence. Obstet Gynecol. 1997;89:790-796.
11. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: A multicenter trial. I. Safety and efficacy. Contraception. 1996;53:321-327.
12. Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception. 1996;54:15-18.
13. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol 3 and 7 days following methotrexate for early abortion. Am J Obstet Gynecol. 1995;173:1578-1584.
14. Schaff EA, Stadalius LS, Eisinger SH, et al. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract. 1997;44:353-360.
15. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338:1241-1247.
16. Peyron R, Aubény E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993;328:1509-1513.
17. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307:532-537.
18. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol. 1994;171: 1366-1372.
19. Hakim-Elahi E, Tovell HMM, Burnhill MS. Complications of first-trimester abortion: A report of 170,000 cases. Obstet Gynecol. 1990;76:129-135.
20. Lichtenberg ES, Grimes D, Paul M. Abortion complications: Prevention and management. In: Paul M, Lichtenberg ES, Borgatta L, Grimes D, Srubblefield P, eds. A Clinician's Guide to Medical and Surgical Abortion. Philadelphia, PA: Churchill Livingstone, 1999.